Eucrates Biomedical Acquisition Corp (EUCRU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EUCRU | ||||
| Company | Eucrates Biomedical Acquisition Corp | ||||
| Price Information | |||||
| Exchange | NASDAQ | ||||
| Open | 10.01 | ||||
| High | 10.02 | ||||
| Low | 10.01 | ||||
| Latest | 10.02 | ||||
| Change | +0.01 | ||||
| % Change | +0.10% | ||||
| Volume | 21,500 | ||||
| 20-Day Average Volume | 1,885 | ||||
| Previous Close | 10.01 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 10.14 | ||||
| 20-Day Raw Stochastic | 16.44% | ||||
| 20-Day Relative Strength | 47.61 | ||||
| Weighted Alpha | +0.28 | ||||
| Today's Opinion | 48% Buy | ||||
| Previous Opinion | 48% Buy | ||||
| Last Month's Opinion | 16% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.18% since 03/01/23 | ||||
| Low | 10.01 on 04/26/23 | ||||
| High | 10.63 on 03/09/23 | ||||
| 1-Month | |||||
| %Chg | -3.33% since 03/21/23 | ||||
| Low | 10.01 on 04/26/23 | ||||
| High | 10.37 on 03/27/23 | ||||
| 3-Month | |||||
| %Chg | +0.30% since 01/25/23 | ||||
| Low | 10.01 on 04/26/23 | ||||
| High | 10.63 on 03/09/23 | ||||
| 6-Month | |||||
| %Chg | -0.20% since 10/20/22 | ||||
| Low | 9.76 on 01/04/23 | ||||
| High | 10.63 on 03/09/23 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | ||||
| Shares Outstanding, K | N/A | ||||
| Annual Sales | 0 | ||||
| Annual Net Income | 2,419,605 | ||||
| Last Quarter Sales | 0 | ||||
| Last Quarter Net Income | 141,754 | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||